jakavi
novartis europharm limited - ruxolitinib (als phosphat) - myeloproliferative disorders; polycythemia vera; graft vs host disease - antineoplastische mittel - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. polycythaemia vera (pv)jakavi ist angezeigt für die behandlung von erwachsenen patienten mit polycythaemia vera, die resistent oder intolerant gegenüber hydroxyurea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.
ropivacain readyfusor 2 mg/ml infusionslösung im applikationssystem
bioq pharma b.v. - ropivacainhydrochlorid monohydrat -
brimonidin stulln sine 2 mg/ml augentropfen, lösung im einzeldosisbehältnis
pharma stulln gmbh - brimonidin tartrat -
amlodipine essential pharmaceuticals 1 mg/ml suspension zum einnehmen
essential pharma (m) - amlodipine besilate - suspension zum einnehmen - 1 mg/ml - amlodipine besilate 1.386 mg/ml - amlodipine
ibuprofen nutra essential 200 mg suspension zum einnehmen im beutel
nutra essential otc - ibuprofen - suspension zum einnehmen im beutel - 200 mg - ibuprofen 200 mg - ibuprofen
ibuprofen nutra essential 400 mg suspension zum einnehmen im beutel
nutra essential otc - ibuprofen - suspension zum einnehmen im beutel - 400 mg - ibuprofen 400 mg - ibuprofen
lisinopril essential pharmaceuticals 1 mg/ml lösung zum einnehmen
essential pharma (m) - lisinopril dihydrat - lösung zum einnehmen - 1 mg/ml - lisinopril dihydrat 1.088 mg/ml - lisinopril
qaialdo
nova laboratories ireland limited - spironolacton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 und 5.
essentiale kapsel
a. nattermann & cie. gesellschaft mit beschränkter haftung - thiaminnitrat, cyanocobalamin, riboflavin, nicotinamid, pyridoxinhydrochlorid, all-rac-alpha-tocopherolacetat (ph.eur.), essentielle phospholipide - kapsel - thiaminnitrat 3.mg; cyanocobalamin 3.µg; riboflavin 3.mg; nicotinamid 15.mg; pyridoxinhydrochlorid 3.mg; all-rac-alpha-tocopherolacetat (ph.eur.) 3.3mg; essentielle phospholipide 175.mg
seractil 300 mg - filmtabletten
gebro pharma gmbh - dexibuprofen - dexibuprofen